AHL Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $830K | Sell |
6,938
-21,965
| -76% | -$2.63M | 0.01% | 937 |
|
|
2017
Q3 | $4.06M | Buy |
28,903
+10,932
| +61% | +$1.53M | 0.07% | 449 |
|
|
2017
Q2 | $2.19M | Buy |
+17,971
| New | +$2.19M | 0.05% | 595 |
|
|
2016
Q1 | – | Sell |
-2,678
| Closed | -$511K | – | 855 |
|
|
2015
Q4 | $511K | Buy |
2,678
+889
| +50% | +$170K | 0.04% | 462 |
|
|
2015
Q3 | $280K | Sell |
1,789
-22,455
| -93% | -$3.51M | 0.04% | 584 |
|
|
2015
Q2 | $4.38M | Buy |
24,244
+1,169
| +5% | +$211K | 0.17% | 243 |
|
|
2015
Q1 | $4M | Buy |
23,075
+15,456
| +203% | +$2.68M | 0.16% | 271 |
|
|
2014
Q4 | $1.41M | Buy |
+7,619
| New | +$1.41M | 0.07% | 546 |
|